Global Aneurysm Diagnostic And Treatment Market Size, Share & Trends Analysis Report by Location (Aortal Aneurysm, Cerebral Aneurysm, Peripheral Aneurysm, Popliteal Aneurysm, Splenic Aneurysm, Mesenteric Aneurysm, and Others), by Bulge Shape (Fusiform Aneurysm and Saccular Aneurysm), by Treatment Approach (Open Surgery, Endovascular Stent Graft Surgery, and Medications), by Diagnosis Method (CT Scans and MRI, X-Ray), and by End-Users (Hospitals, Research Institute, and Diagnosis Institutes) Forecast Period (2022-2028)
The global aneurysm diagnostic and treatment market is anticipated to grow at a significant CAGR of 12% during the forecast period. The rise in the prevalence of aneurysms has been the primary driver of market expansion. Furthermore, medical advancements that include ongoing surgery and diagnostic test and government and non-government organizational initiatives to treat these diseases are further driving the market growth. Additionally, evolving opportunities in emerging economies such as the development of advanced healthcare infrastructure facilities are also expected to propel the growth of the market.
The global aneurysm diagnostic and treatment market is segmented based on location, bulge shape, treatment approach, diagnosis method, and end-user. Based on the location, the market is segmented into aortal Aneurysm, cerebral Aneurysm, peripheral Aneurysm, popliteal Aneurysm, scenic Aneurysm, mesenteric Aneurysm, and other (the visceral). Based on the bulge shape, the market is segmented into a fusiform aneurysm and a saccular aneurysm. Based on the treatment approach, the market is segmented into surgery, endovascular stent graft surgery, and medications. Based on the diagnosis method, it is segmented into CT Scans, MRI, X Rays. Apart from this, by end-users, the market is segmented into hospitals, research institutes, and diagnosis institutes.
Geographically the global aneurysm diagnostic and treatment market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is anticipated to witness a significant share in the global Aneurysm Diagnostic and Treatment market due to increasing healthcare spending and increased population awareness about the diagnosis and treatment of these aneurysms. Furthermore, specialized drug discovery and surgical devices for these diseases in the region also drive the market growth in the North American market. Whereas, Asia-Pacific is expected to be the fastest-growing region in the global Aneurysm Diagnostic and Treatment market. The attributable factors are improving healthcare infrastructure and rising medical tourism in the region. Moreover, the increasing adoption of urban lifestyles among the population, combined with favorable regulatory policies for biosimilars, will fuel the growth of therapeutics for the Aneurysm Diagnostic and Treatment market in the Asia Pacific region.
The key players operating in the global aneurysm diagnostic and treatment market are Terumo Corp., Bentley, Cardinal Health, Indospan Ltd., PDS Biotechnology, and Raumedic AG, among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.
Research Methodology
The market study of the global aneurysm diagnostic and treatment market is incorporated by extensive primary and secondary research conducted by the research team at research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research papers, and news blogs.
- Company websites and their product catalog.
The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
- Global Aneurysm Diagnostic and Treatment Market Research and Analysis by Location.
- Global Aneurysm Diagnostic and Treatment Market Research and Analysis by Bulge Shape.
- Global Aneurysm Diagnostic and Treatment Market Research and Analysis By Treatment Approach.
- Global Aneurysm Diagnostic and Treatment Market Research and Analysis by Diagnostic Method.
- Global Aneurysm Diagnostic and Treatment Market Industrial Fasteners Market Research and Analysis by End-Users.
The Report Covers
- Comprehensive research methodology of the global aneurysm diagnostic and treatment market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global aneurysm diagnostic and treatment market.
- Insights about market determinants that are stimulating the global aneurysm diagnostic and treatment market.
- Detailed and extensive market segments with the regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Bentley
- BraileBiomedical
- Cardinal Health
- PDS Biotechnology
- EndospanLtd.
- Infrascan, Inc.
- Integra Life Sciences Corp.
- Johnson & Johnson, Inc.
- JOTECGmbH
- Lombard Medical, Inc.
- Medtronic PLC
- Microport Scientific Corp.
- RaumedicAgG
- Sophysa Ltd.
- SpiegelbergGmbH
- Terumo Corp.
- VascopsGmbh
- W. L. Gore & Associates, Inc.
